News

News

TRANSVAC-logo_9cm_100225.png

  • About

    • About TRANSVAC
    • Organisational Structure
    • Research Activities
    • Partners

  • Services

    • Overview
    • Technology
    • Immunocorrelates & System Biology
    • Animal Models
    • Clinical Trial & Regulatory Support

  • Training

  • Resources

    • Databases & Sample Sharing
    • Adjuvants
    • Webinars

  • Apply Now

    • Services
    • Training modules

  • Newsroom

    • News
    • Achievements
    • TRANSVAC2 in Numbers

  • Contact us

  • More

    Use tab to navigate through the menu items.
    • LinkedIn Social Icon
    • Twitter Social Icon

    TNA 2: Adjuvants and Delivery systems

    Technology

    Adjuvant and formulation services                                                                 

    Development and characterisation of vaccine formulations with liposomal adjuvants CAF01 and CAF09b                                                     

    Formulation and characterisation of vaccine candidates paired with mucosal or parenteral adjuvants                                                           

    Formulation of antigens in LPS adjuvants                                                 

    Who we are

    Services

    Training courses

    Latest news

    DS

    TRANSVAC-DS

    Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

    • LinkedIn Social Icon
    • Twitter Social Icon

    This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

    Subscribe to European Vaccine Initiative´s Mailing list

    Thanks for submitting!

    You can unsubscribe at any time.

    Privacy Policy  |  Imprint  |  Contact us  |  Back to top

    © 2021 European Vaccine Initiative. Designed by European Vaccine Initiative